Skip to main content

New resources available to accelerate the adoption of novel digital clinical measures in clinical research

Take the fast track to becoming a V3 and V3+ expert

V3 in Action Koneksa_Av

“We did analytics validation [step two of V3] in healthy populations versus disease populations in this case [because] gate and balance features can be recorded in both populations. In many cases, this is an optimal first step because testing novel algorithms [e.g., those developed by Koneksa] may require multiple iterations. – Elena Izmailova, Chief Scientific Officer, Koneksa

Learn more about this V3 in Action story: